Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Assessing Safety and Efficacy of Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure

NCT04205799 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT04205799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04205799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Assessing Safety and Efficacy of Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2020
Completion date
January 15, 2023
Enrollment
57 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

advanced/metastatic cervical cancer